In2Care is a startup from Stichting Startlife , our newly accredited EU|BIC member in Wageningen, Netherlands.
The startup recently received a 10.2 million dollar grant to participate for five years with other partners in the US, UK and Africa in a study funded by a grant from the Bill & Melinda Gates Foundation to test a new method for preventing the transmission of malaria.
The method involves limiting mosquito access to houses by screening windows and installing “eave tubes” that contain a unique type of insecticide-laced netting developed by In2Care that kills the insects as they attempt to enter.

In2Care was founded by two PhDs, Remco Suer and Marit Fahrenorst, from Wageningen University who were working on the biological pest control of malaria transmitted by mosquitoes. They integrated the Wageningen incubator Stichting Startlife in 2012 where they received full support for coaching, business development and access to privileged service providers and advisors from the Startlife network on finance, legal and validation issues. In addition, In 2014 In2care applied for one of the early stage loans delivered by Startlife and for workspace in Kadans Science incubator which is partner of Startlife.